Monday, November 20, 2006

Will prescription pill prices be pushed down?

"Six Ways Congress Could Hurt Big Pharma" is a Forbes.com article which discusses the six bills that are in Congress that could negatively affect pharma profits. Besides bills dealing with Medicare and Medicaid reform, drug importation, and drug safety, there are bills on patent reform and the Prescription Drug User Fee Act reauthorization in Congress. And with the Democrats in the majority next year:

"Wall Street is getting worried. In a note to investors, analysts at Prudential Equity Group fret, 'Democrats are well positioned to force action on drug prices, and contrary to conventional wisdom, a [presidential] veto is not a sure thing.'"
More changes to come in CME Land, methinks.

No comments: